Sartorius AG

EANS-Adhoc: Dynamic growth and overproportionate increase in profitability for the Biotechnology Division | Strong cyclical slump in demand and negative results for the Mechatronics Division | Robust consolidated operating earnings | One-time ...

-------------------------------------------------------------------------------- ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. -------------------------------------------------------------------------------- Preliminary Figures for the First Half of 2009 24.07.2009 Order intake for the Biotechnology Division surged 8.8% (currency-adjusted: +5.8%) to 203.5 million euros (previous year: 187.1 mn euros) and sales revenue rose 7.4% (currency-adjusted: +4.3%) to 197.8 million euros from 184.1 mn euros a year ago. This gain was fueled by business with single-use products at clearly dou-ble-digit growth rates. For the Mechatronics Division, order intake in the first six months fell cyclically from 124.1 million euros to 102.9 million euros (-17.1%; currency-adjusted: 20.3%). At the same time, sales revenue dropped from 119.9 million euros to 98.7 million euros (-17.7%; currency-adjusted: -20.9%). On the whole, the Sartorius Group received orders valued at 306.4 million euros (311.3 mn euros), which equates to a decline of 1.6% (currency-adjusted: -4.6%). Consolidated sales revenue eased 2.5% (currency-adjusted: -5.6%) and is at 296.5 million euros (304.0 mn euros). Consolidated earnings before interest, taxes and amortization and adjusted for one-time extraordinary expenses (underlying EBITA) are at 24.7 million euros (27.0 mn euros), which corresponds to a margin of 8.3% (8.9%). The Biotechnology Division contributed to this growth with 28.0 million euros (20.4 mn euros) and a margin increase from 11.1% to 14.2%. At -3.4 million euros (6.6 mn euros), the Mechatronics Division delivered negative earnings. One-time extraordinary expenses essentially entail provisions for the restructuring program currently being implemented in the Mechatronics Division, and total 16.3 million euros. Without the two non-cash items of amortization and interest for share price warrants, consolidated underlying net profit after minority interest is at 6.4 million euros (9.6 mn euros); the corresponding earnings per share are at 0.37 euro (0.56 euro). Actual consolidated net profit after minority interest amounts to -8.1 million euros (7.3 mn euros). As of June 30, 2009, net debt was reduced to 181.9 million euros (Dec. 31, 2008: 217.6 mn euros). For fiscal 2009, our forecast remains unchanged, with the Biotechnology Division´s revenue expected to grow and its earnings to increase overproportionately. For the Mechatronics Division, we project a double-digit decline in revenue and a negative earnings contribution. Given the continued high uncertainty regarding the global economy, we still consider it not possible to make a precise full-year forecast. Dr. Joachim Kreuzburg, CEO and Executive Board Chairman of Sartorius, will discuss the first-half figures with analysts and investors on Tuesday, July 28, 2009, at 3:15 p.m. Central European Time (CET), in a teleconference. You may dial into the teleconference starting at 3:00 p.m. CET at the following numbers: Germany +49 (0)69 5007 1317; France +33 (0)1 70 99 43 01; UK +44 (0)20 7806 1966; USA +1 718 354 1389 The dial-in code is: 7760640 The webcast and presentation can be viewed at www.sartorius.com. end of announcement euro adhoc -------------------------------------------------------------------------------- ots Originaltext: Sartorius AG Im Internet recherchierbar: http://www.presseportal.ch Further inquiry note: Andreas Wiederhold Team Leader Treasury & Investor Relations Telefon: +49 (0)551 308-1668 E-Mail: andreas.wiederhold@sartorius.com Branche: Biotechnology ISIN: DE0007165607 WKN: 716560 Index: CDAX, Prime All Share, Technologie All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Hamburg / free trade Stuttgart / free trade Düsseldorf / free trade Hannover / free trade München / free trade

Das könnte Sie auch interessieren: